51467-57-3

51467-57-3 structure

Name: (3β)-(3-2H)Cholest-5-en-3-ol
Chemical Name: cholesterol-3-d1
CAS Number: 51467-57-3
Molecular Formula: C₂₇H₄₅DO
Molecular Weight: 387.66
Catalog: Signaling Pathways Others Estrogen Receptor/ERR
Create Date: 2018-03-03 08:00:00
Modify Date: 2024-01-10 17:19:19
Cholesterol-d1 is the deuterium labeled Cholesterol. Cholesterol is the major sterol in mammals and is makes up 20-25% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3][4].

Name	cholesterol-3-d1
Synonyms	3-deuteriocholesterol Cholest-5-en-3-d-3-ol, (3β)- (3β)-(3-H)Cholest-5-en-3-ol 3-2H-cholesterol <3-Trifluormethyl-phenyl)-<2-hydroxy-aethyl>-thioharnstoff

Description	Cholesterol-d1 is the deuterium labeled Cholesterol. Cholesterol is the major sterol in mammals and is makes up 20-25% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3][4].
Related Catalog	Signaling Pathways >> Others >> Estrogen Receptor/ERR
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Casaburi I, et al. Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment. Front Endocrinol (Lausanne). 2018 Sep 11;9:525. [3]. Dietschy JM, et al. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004 Aug;45(8):1375-97. [4]. Fukui K, et al. Effect of Cholesterol Reduction on Receptor Signaling in Neurons. J Biol Chem. 2015 Sep 14.

Density	1.0±0.1 g/cm3
Boiling Point	480.6±14.0 °C at 760 mmHg
Molecular Formula	C₂₇H₄₅DO
Molecular Weight	387.66
Flash Point	209.3±12.4 °C
Exact Mass	387.361145
PSA	20.23000
LogP	9.85
Vapour Pressure	0.0±2.7 mmHg at 25°C
Index of Refraction	1.525

601-54-7

98936-76-6

51467-57-3

Literature: Murari, Martha P.; Murari, Ramaswamy; Baumann, Wolfgang J. Magnetic Resonance in Chemistry, 1985 , vol. 23, # 4 p. 243 - 245

601-54-7

51467-57-3

Literature: Suginome, Hiroshi; Furusaki, Akio; Kato, Kimitoshi; Maeda, Norio; Yonebayashi, Fumihiko Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1981 , p. 236 - 250

Precursor 1
601-54-7
DownStream 0

51467-57-3	130167-69-0
117768-78-2	71472-94-1
50921-65-8	72542-49-5
604-32-0	68138-65-8
2864-50-8	23653-01-2